Literature DB >> 22027265

Anti-cancer effect of bee venom toxin and melittin in ovarian cancer cells through induction of death receptors and inhibition of JAK2/STAT3 pathway.

Miran Jo1, Mi Hee Park, Pushpa Saranya Kollipara, Byeong Jun An, Ho Sueb Song, Sang Bae Han, Jang Heub Kim, Min Jong Song, Jin Tae Hong.   

Abstract

We investigated whether bee venom and melittin, a major component of bee venom, inhibit cell growth through enhancement of death receptor expressions in the human ovarian cancer cells, SKOV3 and PA-1. Bee venom (1-5 μg/ml) and melittin (0.5-2 μg/ml) inhibited the growth of SKOV3 and PA-1 ovarian cancer cells by the induction of apoptotic cell death in a dose dependent manner. Consistent with apoptotic cell death, expression of death receptor (DR) 3 and DR6 was increased in both cancer cells, but expression of DR4 was increased only in PA-1 cells. Expression of DR downstream pro-apoptotic proteins including caspase-3, 8, and Bax was concomitantly increased, but the phosphorylation of JAK2 and STAT3 and the expression of Bcl-2 were inhibited by treatment with bee venom and melittin in SKOV3 and PA-1 cells. Expression of cleaved caspase-3 was increased in SKOV3, but cleaved caspase-8 was increased in PA-1 cells. Moreover, deletion of DR3, DR4, and DR6 by small interfering RNA significantly reversed bee venom and melittin-induced cell growth inhibitory effect as well as down regulation of STAT3 by bee venom and melittin in SKOV3 and PA-1 ovarian cancer cell. These results suggest that bee venom and melittin induce apoptotic cell death in ovarian cancer cells through enhancement of DR3, DR4, and DR6 expression and inhibition of STAT3 pathway.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22027265     DOI: 10.1016/j.taap.2011.10.009

Source DB:  PubMed          Journal:  Toxicol Appl Pharmacol        ISSN: 0041-008X            Impact factor:   4.219


  64 in total

1.  Melittin Constrains the Expression of Identified Key Genes Associated with Bladder Cancer.

Authors:  Zidan Jin; Jie Yao; Nianlin Xie; Libo Cai; Shuai Qi; Zhan Zhang; Bai Li
Journal:  J Immunol Res       Date:  2018-05-03       Impact factor: 4.818

2.  In vitro and in vivo characterization of the anticancer activity of Thai stingless bee (Tetragonula laeviceps) cerumen.

Authors:  Pongvit Nugitrangson; Songchan Puthong; Tawin Iempridee; Wittaya Pimtong; Surachai Pornpakakul; Chanpen Chanchao
Journal:  Exp Biol Med (Maywood)       Date:  2015-08-19

3.  Gain-of-function analogues of the pore-forming peptide melittin selected by orthogonal high-throughput screening.

Authors:  Aram J Krauson; Jing He; William C Wimley
Journal:  J Am Chem Soc       Date:  2012-07-18       Impact factor: 15.419

4.  Multistage Nanovectors Enhance the Delivery of Free and Encapsulated Drugs.

Authors:  Jonathan O Martinez; Michael Evangelopoulos; Rohan Bhavane; Stefania Acciardo; Francesco Salvatore; Xuewu Liu; Mauro Ferrari; Ennio Tasciotti
Journal:  Curr Drug Targets       Date:  2015       Impact factor: 3.465

Review 5.  Therapeutic Properties of Bioactive Compounds from Different Honeybee Products.

Authors:  Laura Cornara; Marco Biagi; Jianbo Xiao; Bruno Burlando
Journal:  Front Pharmacol       Date:  2017-06-28       Impact factor: 5.810

Review 6.  Melittin, a major peptide component of bee venom, and its conjugates in cancer therapy.

Authors:  Islam Rady; Imtiaz A Siddiqui; Mohamad Rady; Hasan Mukhtar
Journal:  Cancer Lett       Date:  2017-05-20       Impact factor: 8.679

7.  Construction of the plasmid coding for the expression of the EGFP-M-IL-2(88Arg, 125Ala) fusion protein and the anti-tumor effects exerted by the fusion protein in HeLa-60 cells.

Authors:  Guangcan Shao; Dongmeng Qian; Haitao Wang; Zhiyong Yan; Ming Hu; Tongmei Wang; Bin Wang
Journal:  Oncol Lett       Date:  2015-04-20       Impact factor: 2.967

8.  Antitumour action on human glioblastoma A1235 cells through cooperation of bee venom and cisplatin.

Authors:  Goran Gajski; Tamara Čimbora-Zovko; Sanjica Rak; Maja Osmak; Vera Garaj-Vrhovac
Journal:  Cytotechnology       Date:  2015-04-28       Impact factor: 2.058

9.  Triple-controlled oncolytic adenovirus expressing melittin to exert inhibitory efficacy on hepatocellular carcinoma.

Authors:  Chun-Yu Qian; Kai-Li Wang; Fan-Fu Fang; Wei Gu; Feng Huang; Fu-Zhe Wang; Bai Li; Li-Na Wang
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

10.  Melittin enhances radiosensitivity of hypoxic head and neck squamous cell carcinoma by suppressing HIF-1α.

Authors:  Xi Yang; Hongcheng Zhu; Yangyang Ge; Jia Liu; Jing Cai; Qin Qin; Liangliang Zhan; Chi Zhang; Liping Xu; Zheming Liu; Yan Yang; Yuehua Yang; Jianxin Ma; Hongyan Cheng; Xinchen Sun
Journal:  Tumour Biol       Date:  2014-07-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.